急性肾损伤后晚期慢性肾病预测模型的推导与外部验证
该研究使用加拿大阿尔伯塔省9973例和安大略省2761例因急性肾损伤住院且出院前eGFR>45 mL/min/1.73 m2的成人数据,推导并外部验证预测急性肾损伤后进展为晚期慢性肾病(出院后1年内eGFR持续<30 mL/min/1.73 m2至少3个月)的多变量模型。推导队列中6个变量独立相关:年龄较大、女性、基线血清肌酐较高、白蛋白尿、急性肾损伤严重程度较高、出院时血清肌酐较高。外部验证队列中该模型C统计量为0.81(95%CI 0.75-0.86),优于仅含年龄、性别和出院肌酐或仅含年龄、性别和AKI分期的简化模型。作者结论为该模型能预测急性肾损伤住院后晚期慢性肾病,但其临床效用需进一步研究。
要点
- 适用人群:因急性肾损伤住院、出院前eGFR>45 mL/min/1.73 m2且存活出院的成人。
- 晚期慢性肾病定义为出院后1年内eGFR持续<30 mL/min/1.73 m2至少3个月,推导队列发生率2.7%(408/9973),外部验证队列2.2%(62/2761)。
- 预测变量共6项:年龄较大、女性、基线血清肌酐较高、白蛋白尿、急性肾损伤严重程度较高、出院时血清肌酐较高。
- 外部验证C统计量0.81(95%CI 0.75-0.86),优于仅含年龄、性别和出院肌酐的简化模型(IDI 2.6%,95%CI 1.1%-4.0%;NRI 13.5%,95%CI 1.9%-25.1%)。
- 作者结论:该模型能预测急性肾损伤住院后晚期慢性肾病,但其临床效用需进一步研究。
适用人群与场景
- 纳入:出院前eGFR>45 mL/min/1.73 m2、因急性肾损伤住院并存活出院的成人;急性肾损伤定义为住院期间血清肌酐升高>0.3 mg/dL或超过出院前基线50%。
- 推导队列来自加拿大阿尔伯塔省(2004年4月至2014年3月住院,随访至2015年3月),外部验证队列来自加拿大安大略省(2004年6月至2012年3月住院,随访至2013年3月)。
- 排除:出院前eGFR≤45 mL/min/1.73 m2者。
诊断标准与关键阈值
- 急性肾损伤定义:住院期间血清肌酐升高>0.3 mg/dL或>出院前基线50%。
- 晚期慢性肾病定义:出院后1年内eGFR持续<30 mL/min/1.73 m2至少3个月。
- 预测模型变量:年龄、性别、基线血清肌酐、白蛋白尿、急性肾损伤严重程度、出院时血清肌酐。
研究设计与关键结果
- 研究类型:预测模型推导与外部验证,使用两个基于人群的队列。
- 推导队列9973例,外部验证队列2761例;推导队列平均年龄66岁(SD 15),外部验证队列69岁(SD 11);各队列女性占40%-43%;平均基线血清肌酐1.0 mg/dL(SD 0.2);超过20%的患者为急性肾损伤2期或3期。
- 晚期慢性肾病在推导队列发生408/9973(2.7%),外部验证队列发生62/2761(2.2%)。
- 推导队列中6个变量独立相关:年龄较大、女性、基线血清肌酐较高、白蛋白尿、急性肾损伤严重程度较高、出院时血清肌酐较高。
- 外部验证队列中,包含6个变量的多变量模型C统计量0.81(95%CI 0.75-0.86)。
- 与仅含年龄、性别和出院血清肌酐的简化模型相比,完整模型IDI 2.6%(95%CI 1.1%-4.0%),分类NRI 13.5%(95%CI 1.9%-25.1%)。
- 与仅含年龄、性别和急性肾损伤分期的简化模型相比,完整模型IDI 8.0%(95%CI 5.1%-11.0%),分类NRI 79.9%(95%CI 60.9%-98.9%)。
证据类型、等级与局限
- 证据类型:预测模型推导与外部验证研究(基于人群的队列)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:使用常规实验室数据的多变量模型能够预测急性肾损伤住院后晚期慢性肾病。
- 作者指出:该模型在临床实践中的效用需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Some patients will develop chronic kidney disease after a hospitalization with acute kidney injury; however, no risk-prediction tools have been developed to identify high-risk patients requiring follow-up.
OBJECTIVE: To derive and validate predictive models for progression of acute kidney injury to advanced chronic kidney disease.
DESIGN, SETTING, AND PARTICIPANTS: Data from 2 population-based cohorts of patients with a prehospitalization estimated glomerular filtration rate (eGFR) of more than 45 mL/min/1.73 m2 and who had survived hospitalization with acute kidney injury (defined by a serum creatinine increase during hospitalization > 0.3 mg/dL or > 50% of their prehospitalization baseline), were used to derive and validate multivariable prediction models. The risk models were derived from 9973 patients hospitalized in Alberta, Canada (April 2004-March 2014, with follow-up to March 2015). The risk models were externally validated with data from a cohort of 2761 patients hospitalized in Ontario, Canada (June 2004-March 2012, with follow-up to March 2013).
EXPOSURES: Demographic, laboratory, and comorbidity variables measured prior to discharge.
MAIN OUTCOMES AND MEASURES: Advanced chronic kidney disease was defined by a sustained reduction in eGFR less than 30 mL/min/1.73 m2 for at least 3 months during the year after discharge. All participants were followed up for up to 1 year.
RESULTS: The participants (mean [SD] age, 66 [15] years in the derivation and internal validation cohorts and 69 [11] years in the external validation cohort; 40%-43% women per cohort) had a mean (SD) baseline serum creatinine level of 1.0 (0.2) mg/dL and more than 20% had stage 2 or 3 acute kidney injury. Advanced chronic kidney disease developed in 408 (2.7%) of 9973 patients in the derivation cohort and 62 (2.2%) of 2761 patients in the external validation cohort. In the derivation cohort, 6 variables were independently associated with the outcome: older age, female sex, higher baseline serum creatinine value, albuminuria, greater severity of acute kidney injury, and higher serum creatinine value at discharge. In the external validation cohort, a multivariable model including these 6 variables had a C statistic of 0.81 (95% CI, 0.75-0.86) and improved discrimination and reclassification compared with reduced models that included age, sex, and discharge serum creatinine value alone (integrated discrimination improvement, 2.6%; 95% CI, 1.1%-4.0%; categorical net reclassification index, 13.5%; 95% CI, 1.9%-25.1%) or included age, sex, and acute kidney injury stage alone (integrated discrimination improvement, 8.0%; 95% CI, 5.1%-11.0%; categorical net reclassification index, 79.9%; 95% CI, 60.9%-98.9%).
CONCLUSIONS AND RELEVANCE: A multivariable model using routine laboratory data was able to predict advanced chronic kidney disease following hospitalization with acute kidney injury. The utility of this model in clinical care requires further research.
参考来源
- James MT, Pannu N, Hemmelgarn BR, et al. Derivation and External Validation of Prediction Models for Advanced Chronic Kidney Disease Following Acute Kidney Injury. JAMA. 2017. PMID: 29136443. doi:10.1001/jama.2017.16326
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。